Previous Article | Next Article ![]()
Applied and Environmental Microbiology, September 2003, p. 5269-5274, Vol. 69, No. 9
0099-2240/03/$08.00+0 DOI: 10.1128/AEM.69.9.5269-5274.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
CINVESTAV IPN, Irapuato 36500, Guanajuato,1 Instituto Nacional de Salud Publica, Centro de Investigación sobre Enfermedades Infecciosas, Cuernavaca 62508,6 Instituto de Biotecnología UNAM, Cuernavaca 62250, Morelos, México,7 Corporación para Investigaciones Biologicas, 7378 Medellín, Colombia,2 Instituto de Microbiología y Zoología Agrícola-INTA, Buenos Aires, Argentina,3 EMBRAPA-Recursos Genéticos e Biotecnologia, Brasília/DF,4 Fundação Oswaldo Cruz FIOCRUZ, Recife PE, Brazil5
Received 16 April 2003/ Accepted 1 July 2003
|
|
|---|
|
|
|---|
The use of entomopathogenic bacteria Bacillus thuringiensis and Bacillus sphaericus as biolarvicides is a viable alternative for insect control (12). B. thuringiensis produces proteinaceous inclusions during sporulation that are toxic towards insect larvae upon ingestion (15). The parasporal body of B. thuringiensis consists of one or more insecticidal
-endotoxins (named Cry and Cyt) (http://www.biols.susx.ac.uk/Home/Neil_Crickmore/Bt/index.html). These toxins are highly specific, are harmless to humans, vertebrates, and plants, and are completely biodegradable, so no residual toxic products accumulate in the environment (15).
The number of known B. thuringiensis strains active on diptera is growing (6, 19). A feature of all mosquitocidal strains is the presence of Cyt toxin, which is not very toxic by itself. The mosquitocidal activity of a B. thuringiensis strain is not only the additive effect of each toxin but a complex synergistic interaction among them. B. thuringiensis subsp. israelensis produces four Cry toxins (Cry4Aa, Cry4Ba, Cry10Aa, and Cry11Aa) and two Cyt toxins (Cyt1Aa and Cyt2Ba) (6), and synergism between these toxins has been reported (4, 18). Interestingly, the presence of the Cyt toxin delays or prevents the development of resistance to Cry toxins (17). B. thuringiensis subsp. israelensis has been used in the field for nearly 20 years with no development of insect resistance (7, 11).
The search for native strains with activity against dipteran species could have an impact on the control of mosquitoes worldwide. Here, we characterized selected strains from Latin American B. thuringiensis collections. The characterization included the identification of mosquitocidal cry and cyt genes by multiplex PCR analysis with novel general and specific primers. B. thuringiensis strains containing some of the previously described cry genes as well as potentially novel Cry proteins were identified. Also, B. thuringiensis strain 147-8906 showed toxic activity against A. aegypti similar to that of B. thuringiensis subsp. israelensis but showed different gene content. This strain has potential interest for insect resistance management.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Characteristics of B. thuringiensis strain collections used in this study
|
|
View this table: [in a new window] |
TABLE 2. Characteristics of general and specific primers for cry1, cry5, cry8, cry9, cry11, cry12, cry13, cry14, cry21, and cyt genes
|
Sequence of PCR products.
PCR products were purified from 1% agarose gels with a QIAquick gel extraction kit as described by the manufacturer (Qiagen, Valencia, Calif.). Purified fragments were sequenced in the facilities of Universidad Nacional Autonoma de Mexico by using the same primers as used for amplification (GenBank no. AY326510 and AY326511). The sequences were analyzed with BLAST and ClustalW (5; http://www.ncbi.nlm.nih.gov/BLAST/).
Plasmid patterns.
B. thuringiensis strains were grown to an optical density at 600 nm of 0.8 in Spizizen medium (0.2% NH4SO4, 1.4% K2HPO4, 0.6% KH2PO4, 0.1% sodium citrate, 0.02% MgSO4-7H2O) with 0.5% glucose, 0.1% Casamino Acids (DIFCO) and 0.01% yeast extract. Cells were washed in TE (50 mM Tris, 10 mM EDTA [pH 7.8]) and incubated for 30 min at 37°C in 10 mg of lysozyme/ml in 0.5 M sucrose, 25 mM Tris, and 10 mM EDTA (pH 8.0). After 10 min at 4°C, lysis buffer (0.2 M NaOH, 1% sodium dodecyl sulfate [SDS]) was added and the mixture was incubated for 5 min at 4°C. A solution of 3 M sodium acetate, pH 4.8, was added and stored for 20 min at -20°C. Particles were centrifuged at 12,000 rpm for 20 min in a Sorvall SS34 centrifuge. Two volumes of ethanol were added, and the mixture was incubated for 20 min at -80°C to precipitate DNA. DNA was centrifuged as above, dissolved in distilled water, and visualized in 0.6% agarose gels.
Protein electrophoresis.
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was performed as described previously (14). Concentrated spore-crystal suspensions on disruption buffer were boiled for 5 min. Protein standards were carbonic anhydrase (29 kDa), ovalbumin (45 kDa), bovine serum albumin (66.2 kDa), phosphorylase B (97.4 kDa), ß-galactosidase (116.25 kDa), and myosin (205 kDa).
Scanning electron microscopy.
Diluted suspensions of spore-crystal complexes were placed on aluminum stubs and air dried. Samples were coated with gold in a Fullam EMS-76 M evaporator for 9 min and examined and photographed with a Philips XL30-ESEM scanning electron microscope operating at a voltage of 10 to 15 kV at x2,000 and x18,000 magnifications.
Bioassays.
Mosquitoes were reared at 28°C, 87% relative humidity, and a 12:12 dark/light photoperiod as follows: C. quinquefasciatus (Recife strain) at Centro de Pesquisas Aggeu Magalhães/FIOCRUZ in Brazil; A. aegypti (CINVESTAV strain) at CINVESTAV-Irapuato in Mexico and (CIB strain) at Corporación para Investigaciones Biologicas in Colombia; and A. albimanus (INSP strain) at Instituto Nacional de Salud Pública in Mexico.
Insecticidal activity of B. thuringiensis strains was screened on larvae of the three mosquito species as described previously (10). Twenty early fourth-instar larvae were placed in 100 ml of dechlorinated water. Ten concentrations (2 to 2,000 ng/ml) of the spore-crystal complex of each strain were added (four repetitions). The B. thuringiensis subsp. israelensis positive control was included in addition to a dechlorinated water control. Larvae were incubated at 28°C and examined after 24 h. The mean 50% lethal concentration was estimated by Probit analysis using statistical parameters (9).
|
|
|---|
Microscopic observation of the crystals.
Figure 1A shows the scanning electron microscopy observation of the crystals produced by strains LBIT315, LBIT320, LBIT348, IB604, and 147-8906. These strains showed small ovoid crystal inclusions very similar to those found in B. thuringiensis subsp. israelensis. The diameter of the crystals was 0.9 to 1.1 µm.
![]() View larger version (75K): [in a new window] |
FIG. 1. Characterization of the selected B. thuringiensis strains. (A) Scanning electron microscopy observation of the spore and crystal mixtures produced by LBIT315, LBIT320, LBIT348, 147-8906, IB604, and B. thuringiensis subsp. israelensis HD567. Arrows point to crystal inclusions (Cry) and spores (Spo). (B) SDS-PAGE of spore-crystal suspensions of selected B. thuringiensis strains. (C) Agarose gel electrophoresis of the plasmid profile present in selected B. thuringiensis and B. thuringiensis subsp. israelensis HD567 strains. MD, megadaltons; OC, open circles.
|
|
View this table: [in a new window] |
TABLE 3. Dose-response insecticidal activities and cry and cyt gene profile present in the selected B. thuringiensis strains
|
Identification of specific cry genes in the B. thuringiensis isolates.
The PCR methodology described here utilized 27 primers to detect 17 different cry and cyt genes described to codify for proteins active against mosquitoes (Table 2). Figure 2A shows the PCR products obtained with control strains. HD1 strain yielded a PCR product only when amplified with the cry2-gen primers. In contrast, B. thuringiensis subsp. israelensis showed the expected PCR products with cry4-spe, cry11-gen, and cyt-gen primers. The B. thuringiensis subsp. jegathesan was used as a control for cry19, cry24, and cry25 genes. B. thuringiensis subsp. jegathesan also showed the expected PCR products when amplified with cry11-gen and cyt2-gen primers.
![]() View larger version (31K): [in a new window] |
FIG. 2. (A) Agarose gel electrophoresis of the PCR products obtained with control strains HD1 B. thuringiensis subsp. kurstaki, HD567 B. thuringiensis subsp. israelensis, and B. thuringiensis subsp. jegathesan. (B) PCR products obtained with some native B. thuringiensis strains. Arrows point to PCR products that showed a different size than expected.
|
Characterization of putative novel cry genes.
The PCR product of strain 147-8906 obtained with cry4B-spe primers was sequenced (GenBank accession no. AY326511). BLAST analysis indicated that it corresponds to the cry30 gene (100% identity). The direct primer hybridizes to the 3'region of this gene, and the reverse primer hybridizes outside of the coding region.
The PCR analysis performed with other B. thuringiensis strains that showed lower toxicity against mosquitoes than B. thuringiensis subsp. israelensis demonstrated that strain 447BrB produced a different size PCR product with the cry11-gen primers (Fig. 2B). The BLAST analysis of the sequence of this PCR product (GenBank no. AY326510) indicated that it corresponds to a new variant of cry11B (72% amino acid identity to Cry11Bb in the sequenced region). However, strain 447BrB presented low toxicity against the mosquito larvae and thus was not further characterized.
|
|
|---|
B. thuringiensis strains that had higher activity than B. thuringiensis subsp. israelensis against A. aegypti and C. quinquefasciatus larvae were identified in spite of their high similarity with this control strain (i.e., similar protein and plasmid profiles and similar cry and cyt genes). Other strains harboring other cry genes were also identified, but they showed lower activity against mosquitoes than B. thuringiensis subsp. israelensis (data not shown). These data support the idea that although a great variability in cry genes codifying for different mosquitocidal toxins exists in nature, one of the most effective combinations of proteins is that present in the B. thuringiensis subsp. israelensis strain, containing Cry4, Cry10, Cry11, and Cyt toxins (15). The higher mosquitocidal activity of the selected strains LBIT315, LBIT320, LBIT348, and IB604 could be due to different factors: the cry and cyt genes detected by PCR may represent fragments of genes encoding novel variants of known proteins; the cry and cyt genes may be identical, but the expression levels of at least some of them may be different; or an undetected factor or protein may be responsible for their higher activity. It will be worthwhile to isolate the cry and cyt genes of these strains to test the individual proteins and sequence these genes to identify differences responsible for the increased toxicity.
On the other hand, we identified an active strain, 147-8906, with different cry gene content than B. thuringiensis subsp. israelensis but with similar activity against A. aegypti. The proteins present in 147-8906 are all active against mosquitoes (S. Ordúz, personal communication) (http://www.biols.susx.ac.uk/Home/Neil_Crickmore/Bt/index.html). These data suggest that this strain may have a potential for the management of B. thuringiensis subsp. israelensis resistance in mosquito populations. Also, strain 147-8906 showed the lowest toxicity against A. albimanus, proving the possibility to select native strains that may be used in the biological control against some specific targets.
The results obtained with strain 447BrB suggest that it may harbor a putative novel cry11B gene. The cloning and expression of the whole gene and the characterization of its potential insecticidal activity against different mosquito species remain to be determined.
This work was supported in part by CYTED III.5, CONACYT Z001, USDA 2002-35302-12539, UC Mexus 2001, Colciencias 4501-07-532-97, and FAO.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»